TECH BIO-TECHNE Corp
Healthcare · Biological Products, (No Diagnostic Substances) · Market cap: $11.4B
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $105.8K | $2.4M |
| 2022-Q3 | $0 | $948.5K |
| 2022-Q4 | $0 | $677.4K |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $26.7K |
| 2023-Q3 | $0 | $7.8M |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $800.6K |
| 2024-Q2 | $0 | $335.4K |
| 2024-Q3 | $0 | $1.2M |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $1.2M |
| 2025-Q2 | $0 | $63.7K |
| 2025-Q3 | $0 | $1.9M |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $116.8K |
| 2026-Q2 | $0 | $320.4K |
| 2026-Q3 | $0 | $0 |
| 2026-Q4 | $0 | $0 |
Bought$105.8K1 buy day
Sold$18.0M21 sell days
Net insider flow-$17.9Mnet selling · 5 years
Latest trade2026-05-08Herr Amy E.
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-05-08 | Sell | Herr Amy E. | Director | 6,636 | $48.28 | $320.4K | 1 |
| 2026-02-17 | Sell | Herr Amy E. | Director | 1,976 | $59.11 | $116.8K | 1 |
| 2025-08-25 | Sell | Nusse Roeland | Director | 17,040 | $56.36 | $960.4K | 1 |
| 2025-08-25 | Sell | BAUMGARTNER ROBERT V | Director | 17,040 | $56.21 | $957.8K | 1 |
| 2025-06-09 | Sell | Herr Amy E. | Director | 1,280 | $49.77 | $63.7K | 1 |
| 2025-02-14 | Sell | Herr Amy E. | Director | 1,860 | $65.96 | $122.7K | 1 |
| 2025-01-27 | Sell | Kelderman Kim | CEO | 13,392 | $77.28 | $1.0M | 2 |
| 2024-08-08 | Sell | BAUMGARTNER ROBERT V | Director | 16,000 | $72.10 | $1.2M | 1 |
| 2024-05-14 | Sell | HIGGINS JOHN L | Director | 4,000 | $83.84 | $335.4K | 1 |
| 2024-03-07 | Sell | Nusse Roeland | Director | 10,400 | $76.98 | $800.6K | 1 |
| 2023-08-30 | Sell | Nusse Roeland | Director | 8,939 | $80.32 | $718.0K | 1 |
| 2023-07-21 | Sell | Kummeth Charles R. | CEO | 80,000 | $88.36 | $7.1M | 1 |
| 2023-06-07 | Sell | Kummeth Charles R. | CEO | 322 | $83.00 | $26.7K | 1 |
| 2022-12-08 | Sell | Furlow Brenda S. | General counsel | 7,450 | $82.12 | $611.8K | 1 |
| 2022-12-07 | Sell | Furlow Brenda S. | General counsel | 800 | $82.01 | $65.6K | 1 |
| 2022-08-11 | Sell | HIGGINS JOHN L | Director | 512 | $385.40 | $197.3K | 2 |
| 2022-08-10 | Sell | HIGGINS JOHN L | Director | 1,992 | $377.10 | $751.2K | 3 |
| 2022-06-08 | Sell | HIGGINS JOHN L | Director | 600 | $366.09 | $219.7K | 1 |
| 2022-06-07 | Sell | Kummeth Charles R. | CEO | 5,104 | $365.00 | $1.9M | 1 |
| 2022-06-07 | Sell | HIGGINS JOHN L | Director | 1,000 | $364.31 | $364.3K | 1 |
| 2022-05-10 | Buy | BAUMGARTNER ROBERT V | Director | 300 | $352.55 | $105.8K | 1 |
| 2021-11-19 | Sell | Kelderman Kim | Other officer | 500 | $505.38 | $252.7K | 2 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Kummeth Charles R. | CEO | $0 | $9.0M | 2023-07-21 |
| Nusse Roeland | Director | $0 | $2.5M | 2025-08-25 |
| BAUMGARTNER ROBERT V | Director | $105.8K | $2.1M | 2025-08-25 |
| HIGGINS JOHN L | Director | $0 | $1.9M | 2024-05-14 |
| Kelderman Kim | CEO | $0 | $1.3M | 2025-01-27 |
| Furlow Brenda S. | General counsel | $0 | $677.4K | 2022-12-08 |
| Herr Amy E. | Director | $0 | $623.6K | 2026-05-08 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
No buying cluster has formed at this company.
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.